195 related articles for article (PubMed ID: 24632382)
1. Comparative reactivity of myeloperoxidase-derived oxidants with mammalian cells.
Rayner BS; Love DT; Hawkins CL
Free Radic Biol Med; 2014 Jun; 71():240-255. PubMed ID: 24632382
[TBL] [Abstract][Full Text] [Related]
2. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.
Pattison DI; Davies MJ; Hawkins CL
Free Radic Res; 2012 Aug; 46(8):975-95. PubMed ID: 22348603
[TBL] [Abstract][Full Text] [Related]
3. Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells.
Lloyd MM; Grima MA; Rayner BS; Hadfield KA; Davies MJ; Hawkins CL
Free Radic Biol Med; 2013 Dec; 65():1352-1362. PubMed ID: 24120969
[TBL] [Abstract][Full Text] [Related]
4. Vascular peroxidase 1 catalyzes the formation of hypohalous acids: characterization of its substrate specificity and enzymatic properties.
Li H; Cao Z; Zhang G; Thannickal VJ; Cheng G
Free Radic Biol Med; 2012 Nov; 53(10):1954-9. PubMed ID: 22982576
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.
Rees MD; Whitelock JM; Malle E; Chuang CY; Iozzo RV; Nilasaroya A; Davies MJ
Matrix Biol; 2010 Jan; 29(1):63-73. PubMed ID: 19788922
[TBL] [Abstract][Full Text] [Related]
6. Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations.
Koelsch M; Mallak R; Graham GG; Kajer T; Milligan MK; Nguyen LQ; Newsham DW; Keh JS; Kettle AJ; Scott KF; Ziegler JB; Pattison DI; Fu S; Hawkins CL; Rees MD; Davies MJ
Biochem Pharmacol; 2010 Apr; 79(8):1156-64. PubMed ID: 19968966
[TBL] [Abstract][Full Text] [Related]
7. Cellular targets of the myeloperoxidase-derived oxidant hypothiocyanous acid (HOSCN) and its role in the inhibition of glycolysis in macrophages.
Love DT; Barrett TJ; White MY; Cordwell SJ; Davies MJ; Hawkins CL
Free Radic Biol Med; 2016 May; 94():88-98. PubMed ID: 26898502
[TBL] [Abstract][Full Text] [Related]
8. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
[TBL] [Abstract][Full Text] [Related]
10. Substrate-dependent metabolomic signatures of myeloperoxidase activity in airway epithelial cells: Implications for early cystic fibrosis lung disease.
Kim SO; Shapiro JP; Cottrill KA; Collins GL; Shanthikumar S; Rao P; Ranganathan S; Stick SM; Orr ML; Fitzpatrick AM; Go YM; Jones DP; Tirouvanziam RM; Chandler JD
Free Radic Biol Med; 2023 Sep; 206():180-190. PubMed ID: 37356776
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the cellular effects of myeloperoxidase-derived oxidants on H9c2 cardiac myoblasts.
Reyes L; Hawkins CL; Rayner BS
Arch Biochem Biophys; 2019 Apr; 665():132-142. PubMed ID: 30872062
[TBL] [Abstract][Full Text] [Related]
13. Hypothiocyanous acid is a more potent inducer of apoptosis and protein thiol depletion in murine macrophage cells than hypochlorous acid or hypobromous acid.
Lloyd MM; van Reyk DM; Davies MJ; Hawkins CL
Biochem J; 2008 Sep; 414(2):271-80. PubMed ID: 18459943
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mono- and dichlorinated tyrosines with carbonyls for detection of hypochlorous acid modified proteins.
Chapman AL; Senthilmohan R; Winterbourn CC; Kettle AJ
Arch Biochem Biophys; 2000 May; 377(1):95-100. PubMed ID: 10775446
[TBL] [Abstract][Full Text] [Related]
15. Interaction of hypohalous acids and heme peroxidases with unsaturated phosphatidylcholines.
Spalteholz H; Wenske K; Arnhold J
Biofactors; 2005; 24(1-4):67-76. PubMed ID: 16403965
[TBL] [Abstract][Full Text] [Related]
16. The role of hypothiocyanous acid (HOSCN) in biological systems.
Hawkins CL
Free Radic Res; 2009 Dec; 43(12):1147-58. PubMed ID: 19905977
[TBL] [Abstract][Full Text] [Related]
17. Reactive Oxygen Species and Neutrophil Function.
Winterbourn CC; Kettle AJ; Hampton MB
Annu Rev Biochem; 2016 Jun; 85():765-92. PubMed ID: 27050287
[TBL] [Abstract][Full Text] [Related]
18. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach.
Pattison DI; Hawkins CL; Davies MJ
Chem Res Toxicol; 2009 May; 22(5):807-17. PubMed ID: 19326902
[TBL] [Abstract][Full Text] [Related]
19. Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride.
Senthilmohan R; Kettle AJ
Arch Biochem Biophys; 2006 Jan; 445(2):235-44. PubMed ID: 16125131
[TBL] [Abstract][Full Text] [Related]
20. Response of Pseudomonas aeruginosa to the Innate Immune System-Derived Oxidants Hypochlorous Acid and Hypothiocyanous Acid.
Farrant KV; Spiga L; Davies JC; Williams HD
J Bacteriol; 2020 Dec; 203(2):. PubMed ID: 33106346
[No Abstract] [Full Text] [Related]
[Next] [New Search]
